The Grant Group

The Grant Group in Bedford, Texas offers Spravato for adults with treatment-resistant depression who have not found relief through conventional antidepressants. FDA-approved in 2019 for use alongside an oral antidepressant, the esketamine nasal spray targets different brain pathways than traditional medications and increases glutamate to improve mood, with some patients experiencing symptom relief within hours or days.

Spravato is administered in the office, followed by a post-treatment observation period during which the team monitors blood pressure and potential side effects such as dissociation, dizziness, or drowsiness. Patients arrange transportation home since they cannot drive afterward. Dr. Grant assesses each patient's eligibility during an initial appointment.

The practice provides psychiatric care including psychotherapy such as cognitive-behavioral therapy and motivational interviewing, along with medication management. The Grant Group is part of the Beacon network of physician-led psychiatric practices.